Cellgen Diagnostics is an early stage venture that is developing a break through Companion Diagnostic platform that will enable Precision Medicine by determining whether a patients genetic profile is a match for the prescribed cancer therapeutic. Running on Cellgen's proprietary platform, each disposable test will yield inclusion / exclusion data, while also leveraging proprietary machine learning algorithms to deliver intelligent, quantitative and actionable results to oncologists in under 3 hours as opposed to the current standard of 10-14 days.

Precision Medicine

The US healthcare system is in a crisis… it is expensive, reactive, inefficient, and focused largely on the one-sized fits all treatments for late stage disease.

View morebullet

Unmet Need

Current Companion Diagnostic tests are specialized kits, which run on expensive and complex technology platforms that are not feasible for clinical settings.
View morebullet

Twitter Feed


Cellgen Diagnostics is an early stage venturedeveloping a companion diagnostics platform. Based in Irvine...

View morebullet